Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients
about
Oxidative stress and diabetic complicationsFEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products.Association of serum bilirubin levels with development and progression of albuminuria, and decline in estimated glomerular filtration rate in patients with type 2 diabetes mellitus.Dialysis-related amyloidosis: pathogenesis focusing on AGE modification.The internalization and metabolism of 3-deoxyglucosone in human umbilical vein endothelial cells.Identification in human atherosclerotic lesions of GA-pyridine, a novel structure derived from glycolaldehyde-modified proteins.Glucose autoxidation induces functional damage to proteins via modification of critical arginine residuesInvolvement of Maillard reactions in Alzheimer disease.Paradox of circulating advanced glycation end product concentrations in patients with congestive heart failure and after heart transplantation.Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findingsRole of N-(carboxymethyl)lysine in the development of ischemic heart disease in type 2 diabetes mellitus.Uremic Toxicity of Advanced Glycation End Products in CKD.Advanced Glycation End Products Induce Obesity and Hepatosteatosis in CD-1 Wild-Type MiceNovel insights in the treatment of diabetic nephropathy.A brief critical overview of the biological effects of methylglyoxal and further evaluation of a methylglyoxal-based anticancer formulation in treating cancer patients.Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanismsVascular calcification: pathophysiology and risk factorsPlasma Proteins Modified by Advanced Glycation End Products (AGEs) Reveal Site-specific Susceptibilities to Glycemic Control in Patients with Type 2 Diabetes.Advanced glycation end products (AGEs)-induced expression of TGF-beta 1 is suppressed by a protease in the tubule cell line LLC-PK1.Detection of noncarboxymethyllysine and carboxymethyllysine advanced glycation end products (AGE) in serum of diabetic patients.Immunological evidence for methylglyoxal-derived modifications in vivo. Determination of antigenic epitopes.Evidence for non-enzymatic glycosylation in Escherichia coli.Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients.Glycation and post-translational processing of human interferon-gamma expressed in Escherichia coli.
P2860
Q29615423-4D81C7B8-7512-4C71-8EB7-3FC8DCDCA25BQ30873486-2A401DB3-CC32-483C-8456-F15E39688143Q33622283-D89C1997-3376-4BDA-9CE9-E87718F2CCAEQ34193025-93A45BC5-3FB8-4081-921C-3F92CC656477Q34490546-435C6990-80B6-4B12-88A9-E703F7B076C8Q34528130-3D638151-0DB4-4DF0-9A29-24AA1F45E76DQ35118391-8EDB8A11-9175-462B-A79E-06D634C68DA3Q35164047-AF194E95-B465-45F0-8403-3ACA4A85917EQ35583145-D2EFDF77-1DD9-4FFC-B8B5-DE5ACEAF4DCCQ35636589-FCD8A20B-9AC8-4E21-9575-EDF3A70D9BD5Q36320068-CC31146D-C939-4CA8-9CD2-8805FE50BD94Q36514906-225FCE68-B917-47E8-B309-F4CCCAE6EB00Q36578536-1B0A9E4A-C41B-4ECB-83A7-DE642E0298AFQ37070946-02E7AE27-83CD-48C3-BE7F-214B7F9297C3Q37183301-2C4CC737-7852-49F6-AED6-4458E1A9998CQ37636453-FB6CD788-D337-4427-B238-B3746D58A2B3Q37649134-589B6684-E242-424B-B153-B38A5E134BE2Q40789140-8398B1E7-50B4-4516-A500-7E6666B087EEQ40789629-E1EB0D5B-3E56-4E08-AF26-0CC0C852A8F2Q41886296-401443AA-1933-4428-9473-AEAABCFE3DF6Q42544383-9C88E1D7-1261-4A44-B841-CEB4397C0C3BQ43544090-D5DC18D6-24CA-43BA-8AB5-71C5EB665141Q46495572-15DF1E88-FB7D-4FA0-9E01-A8F7E350CF01Q54517575-E96A00AD-8D47-4EE2-B705-C2FDF2D4D113
P2860
Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients
description
1997 nî lūn-bûn
@nan
1997 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մարտին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Immunohistochemical detection ...... nd aortas of diabetic patients
@ast
Immunohistochemical detection ...... nd aortas of diabetic patients
@en
Immunohistochemical detection ...... nd aortas of diabetic patients
@nl
type
label
Immunohistochemical detection ...... nd aortas of diabetic patients
@ast
Immunohistochemical detection ...... nd aortas of diabetic patients
@en
Immunohistochemical detection ...... nd aortas of diabetic patients
@nl
prefLabel
Immunohistochemical detection ...... nd aortas of diabetic patients
@ast
Immunohistochemical detection ...... nd aortas of diabetic patients
@en
Immunohistochemical detection ...... nd aortas of diabetic patients
@nl
P2093
P2860
P356
P1476
Immunohistochemical detection ...... nd aortas of diabetic patients
@en
P2093
N Tatemichi
S Miyazaki
T Katsuzaki
T Miyazaki
Y Ishizaki
P2860
P304
P356
10.1172/JCI119285
P407
P577
1997-03-15T00:00:00Z